Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03180684
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:36.805046+00:00
Published At
2023-08-25T00:00:00+00:00
Record Updated At
2023-08-25
Results Posted At
2023-08-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)", "Vulvar Dysplasia", "Vulvar Intraepithelial Neoplasia (VIN)", "VIN2", "VIN3", "Pre-cancerous Lesions of the Vulva", "Human Papillomavirus (HPV)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-25"
protocolSection.identificationModule.nctId
"NCT03180684"
protocolSection.identificationModule.officialTitle
"A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA\u2122 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-08-25"

Study condition terms

  • Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) (protocolSection.conditionsModule.conditions)
  • Vulvar Dysplasia (protocolSection.conditionsModule.conditions)
  • Vulvar Intraepithelial Neoplasia (VIN) (protocolSection.conditionsModule.conditions)
  • VIN2 (protocolSection.conditionsModule.conditions)
  • VIN3 (protocolSection.conditionsModule.conditions)
  • Pre-cancerous Lesions of the Vulva (protocolSection.conditionsModule.conditions)
  • Human Papillomavirus (HPV) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.